Penn Study Points to New Therapeutic Strategy in Chronic Kidney Disease
Perelman School of Medicine at the University of PennsylvaniaChronic kidney disease affects at least one in four Americans who are older than 60 and can significantly shorten lifespan. Yet the few available drugs for CKD can only modestly delay the disease’s progress towards kidney failure. Now, a team has found an aspect of CKD’s development that points to a promising new therapeutic strategy.